In this study, we showed that baicalein increased FOXO3a, a transcription factor with known anti-tumor activity [29] and RUNX3, another tumor suppressor, protein expression in a dose-dependent fashion in A549 and H1650 cells (Figure 4A). This evidence concerns the gene FOXO3 and neoplasm.